Northern Trust Corp Cullinan Oncology, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 470,885 shares of CGEM stock, worth $6.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

470,885

Previous 296,852 58.63%

Holding current value

$6.33 Million

Previous $5.18 Million 52.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$16.03 - $20.86 $2.79 Million - $3.63 Million	174,033 Added 58.63%	470,885 $7.88 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $514,273 - $965,703	32,903 Added 12.47%	296,852 $5.18 Million
Q1 2024 May 14, 2024	SELL	$10.17 - $19.02 $30,235 - $56,546	-2,973 Reduced 1.11%	263,949 $4.5 Million
Q4 2023 Feb 13, 2024	BUY	$7.89 - $10.23 $95,508 - $123,834	12,105 Added 4.75%	266,922 $2.72 Million
Q3 2023 Nov 13, 2023	BUY	$9.05 - $11.72 $165,424 - $214,229	18,279 Added 7.73%	254,817 $2.31 Million
Q2 2023 Aug 11, 2023	SELL	$8.8 - $13.4 $105,952 - $161,336	-12,040 Reduced 4.84%	236,538 $2.55 Million
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $413,681 - $483,033	-40,557 Reduced 14.03%	248,578 $2.54 Million
Q4 2022 Feb 13, 2023	BUY	$9.72 - $13.62 $147,277 - $206,370	15,152 Added 5.53%	289,135 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $55,624 - $72,566	4,706 Added 1.75%	273,983 $3.51 Million
Q2 2022 Aug 12, 2022	BUY	$7.31 - $13.55 $221,741 - $411,025	30,334 Added 12.7%	269,277 $3.45 Million
Q1 2022 May 13, 2022	BUY	$10.47 - $16.75 $79,153 - $126,630	7,560 Added 3.27%	238,943 $2.5 Million
Q4 2021 Feb 08, 2022	BUY	$15.36 - $25.0 $36,556 - $59,500	2,380 Added 1.04%	231,383 $3.57 Million
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $2.18 Million - $2.87 Million	96,629 Added 73.0%	229,003 $5.17 Million
Q2 2021 Aug 13, 2021	SELL	$24.96 - $41.25 $221,295 - $365,722	-8,866 Reduced 6.28%	132,374 $3.41 Million
Q1 2021 May 12, 2021	BUY	$28.0 - $53.42 $3.95 Million - $7.55 Million	141,240 New	141,240 $5.89 Million

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $613M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cullinan Oncology, Inc. Transaction History